From Exhibit to Intervention: The Evolution of SocialTheory

SocialTheory began with a bold idea. Could art and narrative move the needle on understanding complex health decisions?

Our first answer came through Survival Story, a series of community-based exhibits combining visual storytelling with practical opioid overdose response training. The impact went far deeper than numbers. A woman in recovery found the confidence to pursue her dream of becoming a treatment counselor. Clinicians shared that the experience reframed how they viewed opioid use disorder, not as a clinical issue, but as a human condition deserving compassion and connection.

That response confirmed what we had always believed: storytelling isn't just powerful. It's essential.

We founded SocialTheory to scale that belief into something enduring. Today we build narrative-driven decision readiness platforms for specialty medicine, immersive storytelling-driven digital tools grounded in graphic medicine that help people process the emotional weight of complex treatment decisions and prepare for shared decision-making with their care team.

Our platform combines structured reflection, clinician-designed adaptive decision moments, and a personalized patient takeaway, meeting people where they are and helping them get to where they need to be.

Scaling the Impact

To take this approach further, we founded SocialTheory—a mission-driven venture blending technology, narrative, and public health strategy. In partnership with Dartmouth’s DALI Lab, we translated the exhibit into an interactive, web-based platform that supports:

Shared Decision-Making (SDM)
Opioid Risk Mitigation Training
REMS and MATE Act Compliance

The platform uses immersive storytelling and clinical decision-support tools to reframe how providers engage with OUD care—centering on empathy, trust, and evidence.

What We've Seen So Far

In our early digital pilot:

100% of clinicians reported increased confidence in OUD-related decision-making
Many cited storytelling as a key factor in that shift
Emotional engagement and behavioral insight were consistently noted as differentiators from traditional CME

What Comes Next

We’re now preparing a Phase I efficacy study in collaboration with the Institute for Health Policy and Practice at the University of New Hampshire. This next step will formally evaluate the platform’s impact on:

Empathy toward individuals with OUD
Understanding of harm reduction strategies
Confidence in clinical engagement

Expanding into Decision Readiness in Allergy and Immunology

SocialTheory is advancing its platform to focus on decision readiness, with initial applications in allergy and immunology.